Cargando…

Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains

Brain mapping has relied on a small number of routine chemical stains for many decades. The advent of immunomarkers has had a major impact on the ability to define homologous nuclei from one species to another. The first atlas to present a panel of immunomarkers was that of Paxinos et al. (1999a,b)...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Charles R., Paxinos, George, Tokuno, Hironobu
Formato: Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831708/
https://www.ncbi.nlm.nih.gov/pubmed/20204155
http://dx.doi.org/10.3389/neuro.09.013.2010
_version_ 1782178263618027520
author Watson, Charles R.
Paxinos, George
Tokuno, Hironobu
author_facet Watson, Charles R.
Paxinos, George
Tokuno, Hironobu
author_sort Watson, Charles R.
collection PubMed
description Brain mapping has relied on a small number of routine chemical stains for many decades. The advent of immunomarkers has had a major impact on the ability to define homologous nuclei from one species to another. The first atlas to present a panel of immunomarkers was that of Paxinos et al. (1999a,b) in the adult rat brain. The markers used were parvalbumin, calbindin, calretinin, SMI32, tyrosine hydroxylase, and NADPH diaphorase (plus nissl and acetylcholinesterase). The ‘signature’ of a nucleus of interest in a new species can be tested against the findings in the rat. Since the pattern of immunomarkers seems to be conserved in mammalian evolution, such extrapolations can be made with reasonable confidence. A marmoset brain stained with a comprehensive set of immunomarkers has recently been published on the internet (Tokuno et al., 2009) and we are in the process of defining nuclear homologies in this brain by comparison with the same markers in the rat. In this article, we present an example (mapping the amygdala in the marmoset) which demonstrates the application of this immunomarker panel in defining homologies. The technique is particularly valuable in situations where little data on hodology or electrophysiology are available.
format Text
id pubmed-2831708
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-28317082010-03-04 Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains Watson, Charles R. Paxinos, George Tokuno, Hironobu Front Hum Neurosci Neuroscience Brain mapping has relied on a small number of routine chemical stains for many decades. The advent of immunomarkers has had a major impact on the ability to define homologous nuclei from one species to another. The first atlas to present a panel of immunomarkers was that of Paxinos et al. (1999a,b) in the adult rat brain. The markers used were parvalbumin, calbindin, calretinin, SMI32, tyrosine hydroxylase, and NADPH diaphorase (plus nissl and acetylcholinesterase). The ‘signature’ of a nucleus of interest in a new species can be tested against the findings in the rat. Since the pattern of immunomarkers seems to be conserved in mammalian evolution, such extrapolations can be made with reasonable confidence. A marmoset brain stained with a comprehensive set of immunomarkers has recently been published on the internet (Tokuno et al., 2009) and we are in the process of defining nuclear homologies in this brain by comparison with the same markers in the rat. In this article, we present an example (mapping the amygdala in the marmoset) which demonstrates the application of this immunomarker panel in defining homologies. The technique is particularly valuable in situations where little data on hodology or electrophysiology are available. Frontiers Research Foundation 2010-02-26 /pmc/articles/PMC2831708/ /pubmed/20204155 http://dx.doi.org/10.3389/neuro.09.013.2010 Text en Copyright © 2010 Watson, Paxinos and Tokuno. http://www.frontiersin.org/licenseagreement This is an open-access article subject to an exclusive license agreement between the authors and the Frontiers Research Foundation, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
spellingShingle Neuroscience
Watson, Charles R.
Paxinos, George
Tokuno, Hironobu
Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
title Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
title_full Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
title_fullStr Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
title_full_unstemmed Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
title_short Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
title_sort using a panel of immunomarkers to define homologies in mammalian brains
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831708/
https://www.ncbi.nlm.nih.gov/pubmed/20204155
http://dx.doi.org/10.3389/neuro.09.013.2010
work_keys_str_mv AT watsoncharlesr usingapanelofimmunomarkerstodefinehomologiesinmammalianbrains
AT paxinosgeorge usingapanelofimmunomarkerstodefinehomologiesinmammalianbrains
AT tokunohironobu usingapanelofimmunomarkerstodefinehomologiesinmammalianbrains